| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1538-7836.2006.02115.X |
| P698 | PubMed publication ID | 16824187 |
| P50 | author | Monique Breteler | Q19609784 |
| Jacqueline C M Witteman | Q105980953 | ||
| Albert Hofman | Q30121906 | ||
| P2093 | author name string | Lip GY | |
| Conway DS | |||
| Heeringa J | |||
| van der Kuip DA | |||
| P2860 | cites work | The adhesion molecule P-selectin and cardiovascular disease | Q35601863 |
| Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation | Q36843189 | ||
| Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group | Q39522420 | ||
| Does atrial fibrillation confer a hypercoagulable state? | Q40369161 | ||
| Soluble P-selectin and the risk of future cardiovascular events | Q40729226 | ||
| A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study | Q40818460 | ||
| Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study | Q40874709 | ||
| Determinants of disease and disability in the elderly: The Rotterdam elderly study | Q42020555 | ||
| Is the hypercoagulable state in atrial fibrillation mediated by vascular endothelial growth factor? | Q44128109 | ||
| Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study | Q44734148 | ||
| Impact of atrial fibrillation on the risk of death: the Framingham Heart Study | Q45222306 | ||
| The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study | Q46776418 | ||
| Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation | Q47408270 | ||
| Hemostatic state and atrial fibrillation (The Framingham Offspring Study) | Q57073286 | ||
| Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis | Q57416369 | ||
| Platelets and atrial fibrillation | Q28191810 | ||
| Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation | Q28196402 | ||
| Atrial fibrillation as an independent risk factor for stroke: the Framingham Study | Q29614200 | ||
| Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis | Q33744558 | ||
| Antithrombotic therapy for atrial fibrillation | Q33812662 | ||
| Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies | Q34469221 | ||
| Inflammation as a risk factor for atrial fibrillation | Q34543274 | ||
| Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates | Q34754682 | ||
| P433 | issue | 9 | |
| P921 | main subject | atrial fibrillation | Q815819 |
| P304 | page(s) | 1944-1949 | |
| P577 | publication date | 2006-07-05 | |
| P1433 | published in | Journal of Thrombosis and Haemostasis | Q6296004 |
| P1476 | title | A longitudinal population-based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990-1999. | |
| P478 | volume | 4 |
| Q85049938 | A Study of blood soluble P-selectin, fibrinogen, and von Willebrand factor levels in idiopathic and lone atrial fibrillation |
| Q37707301 | Antiplatelet therapy for stroke prevention in atrial fibrillation. |
| Q33725910 | Association between changes in air pollution levels during the Beijing Olympics and biomarkers of inflammation and thrombosis in healthy young adults |
| Q35605552 | Association of hemostatic markers with atrial fibrillation: a meta-analysis and meta-regression |
| Q38174213 | Biomarkers in atrial fibrillation: an overview |
| Q37464600 | Cardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage |
| Q44055036 | Changes in renal function after catheter ablation of atrial fibrillation are associated with CHADS2 and CHA2DS2-VASc scores and arrhythmia recurrences |
| Q37887815 | Clopidogrel hydrogen sulphate for atrial fibrillation |
| Q48135990 | Comparison of diverse platelet activation markers as indicators for left atrial thrombus in atrial fibrillation |
| Q44321220 | Effect of race/ethnicity on the efficacy of warfarin: potential implications for prevention of stroke in patients with atrial fibrillation |
| Q36741141 | Effects of depressive and anxious symptoms on norepinephrine and platelet P-selectin responses to acute psychological stress among elderly caregivers |
| Q36087921 | Evidence-based percutaneous closure of the left atrial appendage in patients with atrial fibrillation |
| Q42163618 | Ex vivo thrombin generation in patients with venous thromboembolic disease or atrial fibrillation on long-term oral anticoagulation |
| Q34512403 | Hemostatic markers are associated with the risk and prognosis of atrial fibrillation: the ARIC study |
| Q64072478 | Impacts of event-specific air quality improvements on total hospital admissions and reduced systemic inflammation in COPD patients |
| Q38333088 | Inflammation and the pathogenesis of atrial fibrillation. |
| Q34585334 | Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studies |
| Q34919089 | Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited |
| Q55059334 | Monocyte-platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillation. |
| Q49349357 | Optimum Risk Assessment for Stroke in Atrial Fibrillation: Should We Hold the Status Quo or Consider Magnitude Synergism and Left Atrial Appendage Anatomy? |
| Q53150344 | Pharmacologic strategies for the prevention of stroke in patients with atrial fibrillation. |
| Q39182923 | Platelets Cellular and Functional Characteristics in Patients with Atrial Fibrillation: A Comprehensive Meta-Analysis and Systematic Review |
| Q39209674 | Predictive Role of Coagulation, Fibrinolytic, and Endothelial Markers in Patients with Atrial Fibrillation, Stroke, and Thromboembolism: A Meta-Analysis, Meta-Regression, and Systematic Review. |
| Q89444277 | Prognostic value of von Willebrand factor in patients with atrial fibrillation: A meta-analysis |
| Q91637605 | The KCa2 Channel Inhibitor AP14145, But Not Dofetilide or Ondansetron, Provides Functional Atrial Selectivity in Guinea Pig Hearts |
| Q37468947 | Von Willebrand Factor Plasma Levels Variability In Nonvalvular Atrial Fibrillation |
Search more.